Task: Answer the multiple-choice question.
Query: Which compound exhibits a -29.259% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCNC(=O)COC(=O)C1CCC(=O)N(c2ccc(OC)cc2)C1c1ccc(OC)cc1
b: O=C(NCCc1ccccc1)c1nnc(CS(=O)(=O)c2ccccc2)o1
Answer: b. O=C(NCCc1ccccc1)c1nnc(CS(=O)(=O)c2ccccc2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCCc1ccccc1)c1nnc(CS(=O)(=O)c2ccccc2)o1
O=C(NCCc1ccccc1)c1nnc(CS(=O)(=O)c2ccccc2)o1
5-(benzenesulfonylmethyl)-N-(2-phenylethyl)-1,3,4-oxadiazole-2-carboxamide